IT News Online – Minerco begins distributing its medicinal mushroom, CBD and Delta 8 lines after launching its flagship facility in Ann Arbor, Michigan

Company further strengthens its first mover advantage after opening in June 2021

KINGSTON, JAMAICA / ACCESSWIRE / April 7, 2021 / Minerco, Inc. (“Minerco” or the “Company”) (OTC PINK: MINE) announced today that it is expected to be the first company in the magic mushroom industry to complete an entire Company opens facility dedicated to distributing its lines of microdosing products in addition to CBD and Delta 8 products, and is also sold by WLLCO, a white label CBD company that the company acquired last month.

The company originally announced on March 29, 2021 that it had signed a lease that will allow it to clearly cement its position as the premier pacemaker in the country’s fast-growing and highly lucrative magic mushroom industry.

Ann Arbor, Michigan, decriminalizes psychedelics, including magic mushrooms

The city of Ann Arbor, Michigan, was one of the first cities in the country to recently decriminalize psychedelic plants. This paved the way for innovative companies like Minerco to quickly brand their product lines as they prepare for a nationwide rollout strategy coupled with decriminalizing more cities across the country, “said Julius Jenge, Chairman and CEO of Minerco, Inc . ” Ann Arbor’s resolution defines entheogenic plants as plants and fungi that contain indolamines, tryptamines, and phenethylamines that can be of psychological and physical benefit to wellness, support and enhancement of religious and spiritual practices, and restoring man’s inalienable and direct relationship with nature. “We firmly believe in the healing powers psychedelic plants can have on patients who continue to suffer from traditional Western medicine, and look forward to introducing Minerco’s treatment for a variety of diseases from depression to insomnia,” concluded Jenge.

About Minerco, Inc. (OTC: MINE)

Minerco, Inc. (OTC: MINE), acquired by Jamaica-based psilocybin research and investment firm, is becoming the world’s first publicly traded company focused on the research, manufacture and sale of psilocybin mushrooms.

Forward-Looking Statements by Minerco, Inc.

This press release contains statements that the company believes to be “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. intend, “plan,” “estimate,” “anticipate,” “believe,” “should” or the negative thereof or similar terminology is generally intended to identify forward-looking statements. Such forward-looking statements are subject to risks and uncertainties that could lead to Actual results will differ materially from those expressed or implied in these statements. Investors should not place undue reliance on forward-looking statements. The company disclaims any obligation to update or revise any forward-looking statements as a result of new information, future events or otherwise .

Contact information:

Minerco, Inc.
Investor Relations
Phone: 323-380-4500

SOURCE: Minerco, Inc.

View source version on accesswire.com:
https://www.accesswire.com/639270/Minerco-to-Begin-Distribution-of-its-Medical-Mushrooms-CBD-and-Delta-8-Product-Lines-Following-Launch-of-Flagship-Facility- in-Ann-Arbor-Michigan

Comments are closed.